BG Medicine Profile

0.07
USD 0.02  22.22%
0.03Last Month High 0.09 
0.06Trading Day  High 0.07 

BG Medicine exotic insider transaction detected

BG Medicine Inc insider trading alert for general transaction of series d preferred stock by Van Der Meer Pieter, the corporate stakeholder, on January 10, 2018. This event was filed by Bg Medicine Inc with SEC on 2011-02-03. Initial filing of beneficial ownership - SEC Form 3 [view details]   

BG Medicine Summary

BG Medicine Inc (BGMD) is traded on OTC Market in USA. It is located in MASSACHUSETTS, U.S.A and employs 5 people. BG Medicine is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Nano-Cap' category with current market capitalization of 1.01 M. BG Medicine Inc has 11.37 M outstanding shares of which 630.05 K shares are currently shorted by private and institutional investors with about 2.66 trading days to cover. BG Medicine currently holds about 1.52 M in cash with (3.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BG Medicine Probability Of Bankruptcy

Ownership Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Ifp Advisors IncCommon Shares75.00.0
Agtc Partners LpCommon Shares863.3 K354 K
View BG Medicine Diagnostics

Selected BG Medicine Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

BG Medicine Against Markets

Current Ratings

BG Medicine 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
11 
Chance of
Financial Distress (0 to 100%)
< 47% 
Equity ratings for BG Medicine Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
BG Medicine, Inc. engages in development and commercialization of diagnostic solutions used to guide the patients suffering from heart failure and related disorders in the United States. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameBG Medicine Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationMASSACHUSETTS, U.S.A
Business Address303 Wyman Street Suite 300, Waltham, MA 02451, United States
ExchangeOTC Market
CIK Number01407038.0
CUSIP08861T107
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.bg-medicine.com
Contact Number781 890 1199
CurrencyUSD - US Dollar

Recommendations

BG Medicine Analyst Recommendations
Target PriceAdvice# of Analysts
5.6Hold1Odds
BG Medicine Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
BG Medicine Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas